IRBESARTAN
- Product NDC
- 72189-205
- 11-digit product format
- 721890205
- Labeler code
- 72189
- Product ID
- 72189-205_2c290c08-d35e-21b4-e063-6394a90a73b9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IRBESARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- direct rx
- Application
- ANDA202910
- Marketing category
- ANDA
- Marketing start
- 2021-04-21
- Substance
- IRBESARTAN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IRBESARTAN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IRBESARTAN | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J0E2756Z7N |
| Rxcui | 200094, 200095, 200096 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-205-90 | 72189020590 | 90 TABLET in 1 BOTTLE (72189-205-90) | 90 tablet | 2021-04-21 | 0000-00-00 | No | No | Current |